Journal Basic Info

  • Impact Factor: 1.809**
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Pneumonia
  •  Internal Medicine
  •  Pharmacology and Therapeutics
  •  Asthma
  •  Trauma
  •  Physiology
  •  Tuberculosis
  •  Pulmonary Medicine


Citation: Ann Clin Case Rep. 2022;7(1):2199.DOI: 10.25107/2474-1655.2199

Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccine (Pfizer-BioNTech BNT162b2): A Case Report

Jo KJ, Kim T, Lim JK, Kim YA and Park SE*

Department of Pediatrics, Pusan National University Children’s Hospital, Republic of Korea

*Correspondance to: Park SE 

 PDF  Full Text Case Report | Open Access


Although Coronavirus Disease 2019 (COVID-19) vaccines have been associated with a low incidence of Multisystem Inflammatory Syndrome in Children (MIS-C), several MIS-C cases following COVID-19 vaccination have been reported globally. Here, we report a case of persistent fever, mucocutaneous inflammation, and elevated inflammatory markers after COVID-19 vaccination. A previously healthy 13-year-old boy presented with fever and headache for two days. He had received a second dose of COVID-19 vaccine (Pfizer-BioNTech BNT162b2) approximately nine weeks prior. Laboratory tests revealed elevated levels of inflammatory markers and Echocardiography revealed normal ventricular function and a normal coronary artery. He had no history of diagnosis of COVID-19, and the severe acute respiratory syndrome coronavirus-2 reverse transcriptase polymerase chain reaction result was negative. After admission, the patient developed a skin rash, bilateral conjunctival injection, abdominal pain, and hypotension. Based on diagnostic criteria, MIS-C was strongly suspected. We initiated intravenous gamma globulin and methylprednisolone. Following treatment, the symptoms improved, and inflammatory markers decreased. We report the first Korean child who developed MIS-C following COVID-19 vaccination.


Coronavirus Disease 2019 (COVID-19); COVID-19 vaccination; Multisystem inflammatory syndrome; Children

Cite the Article:

Jo KJ, Kim T, Lim JK, Kim YA, Park SE. Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccine (Pfizer-BioNTech BNT162b2): A Case Report. Ann Clin Case Rep. 2022; 7: 2199..

Search Our Journal

Journal Indexed In

Articles in PubMed

Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I
 PubMed  PMC  PDF  Full Text
A New Minimally Invasive Procedure for Muscle, Back, Neck Pain and Radiculopathy - The Myofascial Nerve Block
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

A New Method of SARS-CoV-2 Screening for Pregnant Women Based on Non-Invasive Prenatal Test
 Abstract  PDF  Full Text
Extensive Right Coronary Artery Thrombosis in a Patient with Coronavirus Disease 2019
 Abstract  PDF  Full Text
View More...